Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-23

Clinical Trial Update: Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the performance of the desmopressin stimulation test in ACTH-dependent Cushing syndrome. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin (Desmopressin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cushing Syndrome | Phase 2 | Status: RECRUITING